Sage Journals: Discover world-class research

Abstract

Approximately 30% of endometrial cancers are associated with microsatellite instability (MSI) caused by deficiencies in the DNA mismatch repair (MMR) genes (dMMR). MMR testing by immunohistochemistry for MMR proteins and MSI testing by polymerase chain reaction (PCR) are routinely utilized to screen patients with colorectal cancer and endometrial cancer for Lynch syndrome and, more recently, to identify patients eligible for immunotherapy. The Biocartis Idylla™ MSI assay is a fully automated, cartridge-based real-time PCR assay. The assay uses as little as one formalin-fixed paraffin-embedded (FFPE) tumor section and is designed to detect seven novel MSI biomarkers consisting of short homopolymers located in ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A and SULF2 genes. Mutation in two of these markers is considered MSI-H. FFPE of 35 ECs (25 dMMR and 10 microsatellite stable (MSS)) were used in this study. When tumor content was ≤20% on a slide, macrodissection was performed. The overall percent agreement with MMR IHC was 97% (31/32) with sensitivity = 96% and specificity = 100%. Pre-analytic evaluation of the manufacturer's recommended 20% tumor content cut-off is essential to ensure valid results. The Idylla MSI assay offers several advantages over other PCR-based assays including minimal hands-on time, rapid turn-around-time, no requirement for a paired normal sample and the use of FFPE directly without an extraction step.

Keywords

Idylla™ MSI assay microsatellite instability endometrial carcinoma molecular diagnostics homopolymers mononucleotide repeats

Get full access to this article

View all access options for this article.

References

Niessen

Hofstra

Westers

, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer. 2009;48(8):737-744.

Ligtenberg

Kuiper

Geurts van Kessel

Hoogerbrugge

. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients. Fam Cancer. 2013;12(2):169-174.

Hampel

Frankel

Panescu

, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006;66(15):7810-7817.

Garg

Soslow

. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. J Clin Pathol. 2009(8);62:679-684. doi:https://doi.org/10.1136/jcp.2009.064949.

Tafe

Garg

Chew

Tornos

Soslow

. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol. 2010 Jun;23(6):781-789. doi:https://doi.org/10.1038/modpathol.2010.41.

Hendriks

Wagner

Morreau

, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology. 2004;127(1):17-25. doi:https://doi.org/10.1053/j.gastro.2004.03.068.

Dinh

Kohlmann

, et al. Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105(3):569-574. doi:https://doi.org/10.1097/01.AOG.0000154885.44002.ae.

Dillon

Gonzalez

DeMars

Bloch

Tafe

. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Hum Pathol. 2017 Dec;70:121-128. doi:https://doi.org/10.1016/j.humpath.2017.10.022.

Tafe

Riggs

Tsongalis

. Lynch syndrome presenting as endometrial cancer. Clin Chem. 2014 Jan;60(1):111-121. doi:https://doi.org/10.1373/clinchem.2013.206888.

10.

Cortes-Ciriano

Lee

Park

Kim

Park

. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017;6:8:15180.

11.

Bonneville

Krook

Kautto

, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017;2017:PO.17.00073. doi: 10.1200/PO.17.00073.

12.

Lancaster

Powell

Chen

Richardson

; SGO Clinical Practice Committee. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2015;136(1):3-7.

13.

Carethers

. Differentiating Lynch-like from Lynch syndrome. Gastroenterology. 2014;146(3):602-604.

14.

Mensenkamp

Vogelaar

van Zelst-Stams

, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology. 2014;146(3):643-646.e8.

15.

Marcus

Lemery

Keegan

Pazdur

. FDA approval summary: pembrolizumab for the treatment of microsatellite instability-high solid tumors. Clin Cancer Res. 2019. doi:https://doi.org/10.1158/1078-0432.CCR-18-4070

16.

Boland

Thibodeau

Hamilton

, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248-5257.

17.

Umar

Boland

Terdiman

, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261-268.

18.

Bacher

Flanagan

Smalley

, et al. Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers. 2004;20(4-5):237-250.

19.

Murphy

Zhang

Geiger

, et al. Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn. 2006;8(3):305-311.

20.

Snir

Rottmann

Wong

Buza

Hui

. Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation. Mod Pathol. 2010;32(5):650-658. doi:https://doi.org/10.1038/s41379-018-0179-3.

21.

Wang

Shi

Eisenberg

Vnencak-Jones

. Differences in microsatellite instability profiles between endometrioid and colorectal cancers: a potential cause for false-negative results? J Mol Diagn. 2017;19(1):57-64.

22.

Hampel

Frankel

Panescu

, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006;66(15):7810-7817.

23.

Buttin

Powell

Mutch

, et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet. 2004;74(6):1262-1269.

24.

Wijnen

de Leeuw

Vasen

, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet. 1999;23(2):142-144.

25.

Billingsley

Cohn

Mutch

Stephens

Suarez

Goodfellow

. Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing. Cancer. 2015;121(3):386-394.

26.

Middha

Zhang

Nafa

, et al. Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data. JCO Precis Oncol. 2017;2017:PO.17.00084. doi:10.1200/PO.17.00084.

27.

Hempelmann

Scroggins

Pritchard

Salipante

. MSIplus for integrated colorectal cancer molecular testing by next-generation sequencing. J Mol Diagn. 2015;17(6):705-714.

28.

Dong

Costigan

Howitt

. Targeted next-generation sequencing in the detection of mismatch repair deficiency in endometrial cancers. Mod Pathol. 2019;32(2):252-257.

29.

Latham

Srinivasan

Kemel

, et al. Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer. J Clin Oncol. 2019;37(4):286-295.

30.

Zhao

Thienpont

Yesilyurt

, et al. Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks. Elife. 2014;3:e02725. doi:10.7554/eLife.02725.

31.

Kim

Laird

Park

. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell. 2013;155(4):858-868.

32.

Kim

Park

. A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies. Cancer Res. 2014;74(22):6377-6382.

33.

Maertens

De Craene

Rondelez

, et al. Detection of microsatellite instability (MSI) with the Idylla™ MSI test in colorectal cancer samples. Ann Oncol. 2017;28(suppl 5):v22-v42. doi:https://doi.org/10.1093/annonc/mdx363.054.

34.

De Craene

Feng

Rondelez

, et al. Detection of microsatellite instability (MSI) with a novel panel of biomarkers in gastric cancer samples. Ann Oncol. 2017;28(suppl 5):v209-v268. doi:https://doi.org/10.1093/annonc/mdx369.081.

35.

De Craene

Van de Velde

Rondelez

, et al. Detection of microsatellite instability (MSI) in colorectal cancer samples with a novel set of highly sensitive markers by means of the Idylla MSI Test prototype. J Clin Oncol. 2018;36(15_suppl):e15639-e15639.

36.

McConechy

Talhouk

Li-Chang

, et al. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. Gynecol Oncol. 2015;137(2):306-310.

37.

Libera

Sahnane

Pepe

, et al. Critical aspects of microsatellite instability testing in endometrial cancer: a comparison study. Hum Pathol. 2022 Oct;128:134-140. doi:https://doi.org/10.1016/j.humpath.2022.07.014.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.39 MB

Detection of Microsatellite Instability in Endometrial Carcinoma Using a Novel Homopolymer Assay

Abstract

Keywords

Get full access to this article

References

Supplementary Material